Even though the transplants were decalcified and, therefore, did not allow us to determine the mineralization of the newly formed bone within the ossicles, our datasets clearly indicated that the Fgfr1+/N330I variant leads to skeletal dysplasia and impaired bone metabolism. This evidence concerns the gene FGFR1 and skeletal dysplasia.